TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
JANX

Janux Therapeutics Inc

Healthcare · Biotechnology

17.00$ +2.5% vs. previous close Closing price · As of: Sep 21, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow JANX
Line item 2019 2020 2021 2022 2023 2024 2025
+116.7% +769.2% +644.2% +132.5% +5.4% -1.5%
+1,100.0% +9,497.2% +149.0% +16.3% +65.1% +21.8%
+742.3% +234.9% +155.2%
+2,173.0% -51.6% -253.3% +880.1%
+0.0% +0.0% +334.9% -71.3% -80.6% +190.5%
+0.0% +0.0% -170.7% +526.4% +16.6%
-37.5% +7,121.9% -87.0%
+188.1% +3,254.1% -99.9% +11,809.6% +1,097.7% -99.3%
+4,059.9% +299.5% -44.6% -303.4% -191.9%

Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?